Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D012163', 'term': 'Retinal Detachment'}], 'ancestors': [{'id': 'D012164', 'term': 'Retinal Diseases'}, {'id': 'D005128', 'term': 'Eye Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 206}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2009-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2009-11', 'completionDateStruct': {'date': '2009-06', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2009-11-24', 'studyFirstSubmitDate': '2009-11-24', 'studyFirstSubmitQcDate': '2009-11-24', 'lastUpdatePostDateStruct': {'date': '2009-11-25', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2009-11-25', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2009-06', 'type': 'ACTUAL'}}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['anticoagulant agents', 'antiplatelet agents', 'vitreoretinal surgery', 'Patients suffered from retinal detachment'], 'conditions': ['Retinal Detachment']}, 'descriptionModule': {'briefSummary': 'Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery with peribulbar anesthesia.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Take or no anticoagulant treatment before surgery,\n* Vitreoretinal surgery\n\nExclusion Criteria:none\n\n* No surgery\n* Anesthetic complication'}, 'identificationModule': {'nctId': 'NCT01020656', 'briefTitle': 'Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery', 'organization': {'class': 'OTHER', 'fullName': 'Centre Hospitalier Universitaire Dijon'}, 'officialTitle': 'Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery', 'orgStudyIdInfo': {'id': 'MARIE02'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'group 1', 'description': 'patients with no anticoagulants used as the control group'}, {'label': 'group 2', 'description': 'patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)'}, {'label': 'group 3', 'description': 'patients treated with aspirin'}, {'label': 'group 4', 'description': 'patients treated with clopidogrel therapy'}, {'label': 'group 5', 'description': 'patients treated with both anticoagulant and aspirin medications'}, {'label': 'group 6', 'description': 'patients treated with both anticoagulant and clopidogrel medications'}, {'label': 'group 7', 'description': 'patients treated with both aspirin and clopidogrel medications'}]}, 'contactsLocationsModule': {'locations': [{'zip': '21000', 'city': 'Dijon', 'state': 'Burgundy', 'country': 'France', 'facility': 'Ophthalmology Unit CHU Dijon', 'geoPoint': {'lat': 47.31344, 'lon': 5.01391}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Centre Hospitalier Universitaire Dijon', 'class': 'OTHER'}, 'responsibleParty': {'oldNameTitle': 'Professor Catherine Creuzot-Garcher', 'oldOrganization': 'Centre Hospitalier Universitaire Dijon'}}}}